$is_valid_institution:
$is_valid_institution_group_access: no
$valid_institution_id:

Editorial Advisory Board and Affiliated Scholars

Rick Audas (Ph.D., M.A., M.B.A., B.B.A.)

Rick Audas is an Associate Professor of Health Statistics and Economics in the Division of Community Health and Humanities, Faculty of Medicine, Memorial University.  His work primarily involves the analysis of complex survey and administrative databases for health and social policy purposes.  Dr. Audas has authored numerous academic papers and reports for governments and NGOs.  Prior to joining Memorial, he was appointed at University of New Brunswick. He has also held appointments at Otago University (New Zealand) and Bangor, Newcastle and Manchester University (all in the UK).

Brian Ferguson (Ph.D., M.A., B.A.)

Brian Ferguson is a professor of economics at the University of Guelph, where he teaches health economics and history of economic thought.  Dr. Ferguson is the co-author of two books on the modelling of dynamic economic processes and articles on health economics with a focus on the economic modelling of addictive substances.  His past research includes work on the economic implications of population ageing.  He has written several papers on health policy and economics for the Atlantic Institute for Market Studies and has worked at the Kansas Health Institute and Health Canada, and is a member of the editorial board of the journal Substance Use and Misuse. His current research includes the modelling of pharmaceutical pricing decisions in a long run dynamic framework.  He is also working, in conjunction with Prof. Audrey Laporte of the University of Toronto, on a series of lectures on health economics. 

John R Graham (M.B.A., B.A.)

John R. Graham is Vice-President, Payment and Health Care Delivery Policy, at the Advanced Medical Technology Association in Washington, DC. He is a Senior Fellow of the National Center for Policy Analysis, an Adjunct Scholar of the Mackinac Center for Public Policy, and member of the Board of Visitors of the Benjamin Rush Society of medical students and physicians. Mr. Graham received his M.B.A. from the London Business School (England) and his B.A. (with Honors) in economics and commerce from the Royal Military College of Canada.  He is a Chartered Alternative Investment Analyst (CAIA Charterholder) and is an affiliate member of the Chartered Financial Analyst (CFA) Society of Washington.  

Devon Herrick (Ph.D., M.P.A.)

Devon Herrick is a health economist and senior fellow with the USA-based (Washington, D.C. and Dallas, TX) National Center for Policy Analysis. He is a preeminent expert on 21st century medicine, including the evolution of Internet-based medicine, consumer driven health care and key changes in the global health market. He was among the first to identify and publish in-depth studies on medical tourism, telemedicine, and "shopping for drugs" strategies. Dr. Herrick concentrates on a variety of critical American health care issues, such as health insurance and the uninsured, patient empowerment and trends in state health policy reform. He has conducted numerous cutting-edge research projects for the NCPA. Dr. Herrick writes regularly on health policy for the NCPA and other research organizations. He is a preferred speaker on health policy issues and his comments have appeared in hundreds of newspapers nationwide in the USA, as well as on television and radio. Dr. Herrick has a Ph.D. in Political Economy and a Master of Public Affairs from the University of Texas at Dallas. Dr. Herrick's dissertation research examined patient empowerment through empirical analysis of the Internet and disease advocacy. He also holds advanced degrees in finance. 

Yanick Labrie (M.A., B.A.)

Yanick Labrie is a health economist and public policy consultant living in Montreal. He holds a bachelor’s degree in economics from Concordia University and a master’s degree in economics from the Université de Montréal. Mr. Labrie’s career in health policy spans more than ten years. He has worked as an economist at the Montreal Economic Institute, the Center for Interuniversity Research and Analysis on Organizations (CIRANO) and was a lecturer at HEC Montréal’s Institute of Applied Economics. He authored or co-authored more than 25 research papers and studies related to healthcare and pharmaceutical policies. Many of his articles have appeared in The Globe and Mail, The National Post, The Ottawa Citizen, The Montreal Gazette, La Presse and Le Devoir, among other newspapers. He is frequently invited to participate in conferences and debates, and to comment on economic affairs in the media. He has spoken at international conferences in Montreal and in Toronto on the lessons to be learned from Europe’s health care systems. He has been invited to give testimonies at numerous parliamentary commissions and working groups on a wide range of topics and has also done some work as an expert witness.

Katia Mohindra (Ph.D., M.Sc.)

Katia Mohindra is a public health researcher. Dr. Mohindra holds a Ph.D. in public health (Université de Montréal). She has worked for a number of research institutions, including the Institute of Population Health and the Unité de santé internationale, and has worked on collaborative research projects in Asia, sub Saharan Africa, and Latin America. She is the author of Women's Health and Poverty Alleviation in India and has published over 30 peer reviewed articles. Drawing on her extensive international experience, her transdisciplinary research involves investigating how to improve access to health and other basic services for poor women and marginalised populations. 

Neil Mohindra (M.B.A., B.A.)

Neil Mohindra has worked for the Financial Services Commission of Ontario as Policy Manager for the Joint Forum Secretariat, Joint Forum of Financial Market Regulators from 2006 to 2012 where he coordinated projects for Canadian provincial securities, pension and insurance regulators. He also worked for the Insurance Bureau of Canada where he coordinated industry positions for legislative and regulatory reviews. Prior to that, he was a policy analyst on financial sector issues at the Department of Finance Canada. More recently, Mr. Mohindra has worked in Mauritius where he overhauled the policy team of a local financial regulator. Mr. Mohindra has also worked Director of the Centre for Financial Policy Studies at the Fraser Institute, where he published a number of papers and articles on financial regulation and the Canadian financial services sector. His commentaries appeared in several newspapers, and he has frequently appeared as a commentator in the media including BNN. He holds a BA (Hons) in Social Sciences (Economics) and an MBA in Finance and Strategic Management.

Nigel Rawson (Ph.D., M.Sc.)

Nigel Rawson is a pharmacoepidemiologist, pharmaceutical policy researcher, and President of Eastlake Research Group in Oakville, Ontario. Educated in the United Kingdom, he holds an M.Sc. in statistics and a Ph.D. in pharmacoepidemiology. Dr. Rawson has performed epidemiologic studies of the use of drugs and their outcomes for over 35 years and published more than 120 book chapters and articles in peer-reviewed journals. He is also the author of the monograph “Drug Safety: Problems, Pitfalls and Solutions in Identifying and Evaluating Risk” published by Friesenpress. He held academic research positions in the United Kingdom until the end of 1989 and subsequently held professorships at the University of Saskatchewan and Memorial University of Newfoundland in Canada. His research activities focused on population-based studies of the use and safety of drugs using administrative healthcare utilization data and the evaluation of issues impacting access to new drugs. Dr. Rawson has also been a senior researcher in an independent research centre in one of the United States’ largest health insurers, where he collaborated with the Food and Drug Administration on drug safety studies, and GlaxoSmithKline’s only epidemiologist in Canada providing advice and analysis for the company’s current and developing medicines and vaccines. Dr. Rawson established Eastlake Research Group in 2012 with a mission to create data-driven responses to pharmaceutical and health policy issues. 

Mayvis Rebeira (Ph.D., M.A., M.B.A., B.Sc)

Mayvis Rebeira obtained her Ph.D. in Health Economics from the Dalla Lana School of Public Health at the University of Toronto. Dr. Rebeira holds a Master’s Degree in Economics from the University of Toronto. She has led economic evaluations, strategic pricing, policy development and numerous finance projects for both the government and the private sector. Dr. Rebeira has also published in the field of health technology assessments, economic evaluations of drugs and medical devices, and health outcomes research.  Her current research interests include developing methodologies for economic evaluation of new technologies and economics issues on aging and longevity. 

Mark Rovere (Ph.D. Candidate, M.A., B.A.)

Mark Rovere is a Senior Policy Advisor in the Health System Strategy and Policy Division at the Ontario Ministry of Health and Long-Term Care. Mr. Rovere was previously Associate Director (2010 to 2012) and Senior Policy Analyst (2006 to 2010) in the health policy research centre at the Fraser Institute. Mr. Rovere holds an Honours Bachelor's degree and a Master's Degree in Political Science from the University of Windsor, and is currently completing a Ph.D. in Health Services Research (health policy) at the University of Toronto's Institute of Health Policy, Management and Evaluation (IHPME). He has authored and co-authored numerous studies and articles on a wide-range of health and pharmaceutical policy related issues including the sustainability of government health expenditures in Canada, wait times for medical services, access to new medicines, Canadian and American prescription drug spending, and international health system comparisons. His commentaries have appeared in newspapers across Canada, and Mr. Rovere has regularly appeared on radio and television programs across the country to discuss his research and health policy issues more generally. 

Brett J Skinner (Ph.D., M.A., B.A.)

Brett J Skinner is the Founder and CEO of Canadian Health Policy Institute (CHPI) and the Editor of CHPI's online journal Canadian Health Policy. Dr. Skinner was previously Executive Director Health and Economic Policy at Innovative Medicines Canada (2013 to 2017); and he was also previously CEO (2010 to 2012) and Director of Health Policy Studies (2004 to 2012) at Fraser Institute. Dr. Skinner has a B.A. from the University of Windsor, an M.A. through joint studies between the University of Windsor and Wayne State University (Detroit), and a Ph.D. from Western University (aka University of Western Ontario, London), where he has lectured in both the Faculty of Health Sciences and the Department of Political Science. Dr. Skinner is the principal author or co-author of one book and over 60 major health policy research publications. His work has been published by think-tanks including Canadian Health Policy Institute (Toronto), Fraser Institute (Vancouver), Atlantic Institute for Market Studies (Halifax), Pacific Research Institute (San Francisco), Israel National Institute for Health Policy and Health Services Research (Tel Aviv), Galen Institute (Washington, D.C.), International Policy Network (London) and American Enterprise Institute (Washington, D.C.). His work has also been published in academic journals including Economic AffairsPharmacoeconomics,  and Alimentary Pharmacology & Therapeutics. In 2003 he was a co-author on a project that won the Atlas Economic Research Foundation’s Sir Antony Fisher Memorial Award for innovative projects in public policy. Dr. Skinner’s book, Canadian Health Policy Failures: What’s wrong? Who gets hurt? Why nothing changes, was a finalist for Atlas’ 2009 Fisher book prize. He has also authored hundreds of opinion-editorials published in National Post, Financial Post, Globe and Mail, Toronto Sun, Ottawa Citizen, La Presse, Montreal Gazette, Calgary Herald, Vancouver Sun, Chicago Sun Times, and other major daily newspapers. Dr. Skinner appears and is cited frequently as a health policy expert in the media. He has presented his research at conferences and events in Canada, the United States, Israel and South Africa. Dr. Skinner has provided expert testimony about his research in several Canadian legal cases, and he has testified on three occasions before the House of Commons Standing Committee on Health in Ottawa. He has also briefed bi-partisan Congressional policy staff at the U.S. Capitol in Washington, D.C.

Shahzia Teja (M.A., B. Comm.)

Shahzia Teja is an Economist with the Ontario Ministry of Finance. Ms. Teja’s academic interests include health and labour economics, and her work has been published in the journal Canadian Public Policy. She has an M.A. in Economics and a B.Comm. in Finance from the University of Guelph and is a member of the Canadian Economics Association. Ms. Teja is interested in the profound and tangible ways in which healthcare systems affect people. Her empirical research focuses on the welfare and distributional impacts of health policy. She is also interested in the role incentives play in achieving better outcomes both for providers and patients, especially as it relates to the funding mechanisms for health professionals and hospitals.

Kimberley Tran (M.A.)

Kimberley Tran is an economist who has conducted health policy research and consulted in market access, forecasting, government regulations, payer and industry trends, health economics and commercial effectiveness.  She was previously HEOR-Market Access Consultant with IMS Health Canada, a global health information, services and technology provider. Ms. Tran has contributed to health industry publications such as the IMS Provincial Reimbursement Advisor and PharmaFocus as well as health economic research study plans, in addition to numerous socio-economic and business publications.  Ms. Tran has also served as policy advisor and Economist with the Nova Scotia Department of Finance and the Atlantic Provinces Economic Council developing fiscal policies and legislation, advising federal-provincial affairs, and conducting budget and sector competitiveness analyses. Ms. Tran has a graduate degree in economics from Dalhousie University.

Subscribe image

Opinions

News